Andolast, also known as CR-2039, an anti-allergic agent for the treatment of bronchial asthma, chronic obstructive pulmonary disease (COPD). Andolast acts at different cellular levels to inhibit immunoglobulin E synthesis. Andolast proved to be significantly more effective than placebo in improving airflow, and in controlling asthma symptoms both during day and night.
Molecular Weight:
333.31
CAS Number:
[132640-22-3]
Formula:
C15H11N9O
Target:
PDE|||Others
T26628
* VAT and and shipping costs not included. Errors and price changes excepted
